MCL1 and neoplasm: For example, IL-6 interacts with the receptor JAK and induces STAT-3 activation [103], which triggers oncogenes such as myeloid cell leukemia-1 (MCL-1) and upregulates proliferative genes, Cyclin-D1, in tumor cells [105].